ARCELIS
Dead / Cancelled — Cancelled — Section 8 (as of 17 Jul 2020)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 77983602
- Registration number
- 4448058
- Mark type
- Stylized text
- Filed
- 07 May 2007
- Published for opposition
- 12 Apr 2011
- Registered
- 10 Dec 2013
- Attorney of record
- Holly A. Coldiron
Goods and services
- Class 005 — Pharmaceuticals: Cell preparations, cellular vaccines and cellular biologics for the treatment of cancer and infectious diseases by autologous cell-based immunotherapy
Owner
- Argos Therapeutics, Inc., Durham, NC, US
- Argos Therapeutics, Inc., Durham, NC, US
- Argos Therapeutics, Inc., Durham, NC, US
Prosecution history
- 17 Jul 2020 — CANCELLED SEC. 8 (6-YR)
- 10 Dec 2018 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 10 Dec 2013 — REGISTERED-PRINCIPAL REGISTER
- 05 Nov 2013 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 04 Nov 2013 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 30 Oct 2013 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 09 Oct 2013 — STATEMENT OF USE PROCESSING COMPLETE
- 02 Oct 2013 — USE AMENDMENT FILED
- 09 Oct 2013 — DIVISIONAL PROCESSING COMPLETE
- 02 Oct 2013 — DIVISIONAL REQUEST RECEIVED
- 02 Oct 2013 — TEAS REQUEST TO DIVIDE RECEIVED
- 02 Oct 2013 — TEAS STATEMENT OF USE RECEIVED
- 10 May 2013 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 May 2013 — NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
- 08 May 2013 — SOU EXTENSION 2 GRANTED